Straumann Group shareholders approve all proposals

10.04.25 16:37 Uhr

Werte in diesem Artikel
Aktien

94,70 CHF -3,50 CHF -3,56%

Straumann Holding AG / Key word(s): AGMEGM/Dividend
Straumann Group shareholders approve all proposals

10.04.2025 / 16:37 CET/CEST

Wer­bung


Basel, 10 April 2025 – Today at the Annual General Meeting (AGM) of Straumann Holding AG, the Straumann shareholders approved all proposals put forward by the Board of Directors. The meeting was attended by 230 shareholders, who together with the independent voting representative, represented 71.4% of the total share capital. 

The shareholders approved the following:

  • The management report, the annual financial statements, and the consolidated financial statements for the 2024 business year
  • The non-financial report for the 2024 business year
  • The compensation report for the 2024 business year, in a consultative vote
  • The appropriation of earnings and the dividend payment for the 2024 business year of CHF 0.95 per share. The dividend is paid as follows: CHF 60 million (CHF 0.38 per share) out of capital contribution reserves and about CHF 90 million (CHF 0.57 per share) out of retained earnings, leaving a balance of approximately CHF 1.9 billion to be carried forward. After the deduction of 35% Swiss withholding tax, the dividend paid out net will be CHF 0.75 per share. The dividend will be paid out as of 16 April 2025. The ex-dividend date is 14 April 2025.
  • The adjustment of the legal capital reserves and legal retained earnings
  • Discharge of the Board of Directors and the Executive Management for the 2024 business year
  • The fixed compensation of the Board of Directors collectively for the next term
  • The compensation of the Executive Management
  • The re-election of Petra Rumpf as Member and Chair of the Board, and the re-election of Xiaoqun Clever-Steg, Olivier Filliol, Marco Gadola, Stefan Meister, Thomas Straumann, and Regula Wallimann as Board Members – each for a term of one year.
  • The re-election of Olivier Filliol, Marco Gadola and Regula Wallimann to the Human Resources & Compensation Committee for a term of one year
  • The re-election of Neovius AG in Basel as the independent voting representative for a term of one year
  • The re-election of Ernst & Young AG, Basel, as auditors for the 2024 business year

The voting results are attached to this release.

The next ordinary general meeting of Straumann’s shareholders will be convened on 17 April 2026 at the Basel Congress Center.

Wer­bung

About Straumann Group

The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Medentika, Neodent, NUVO, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials and digital solutions for use in tooth correction, replacement and restoration or to prevent tooth loss.

Headquartered in Basel, Switzerland, the Group currently employs close to 12’000 people worldwide. Its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.

 

 

Straumann Holding AG, Peter Merian-Weg 12, 4002 Basel, Switzerland   

Wer­bung

 Phone: +41 (0)61 965 11 11

Homepage: www.straumann-group.com

 

Contacts:

Corporate Communication

Silvia Dobry: +1 (0)61 965 15 62
Frank Keidel +41 (0)61 965 19 76

E-mail: corporate.communication@straumann.com

Investor Relations

Marcel Kellerhals: +41 (0)61 965 17 51

Derya Güzel +41 (0)61 965 18 76

E-mail: investor.relations@straumann.com

 

Disclaimer

This press release contains forward-looking statements, including statements regarding the beliefs, expectations and assumptions of future results, performance or achievements of Straumann Group, that are based upon information available to Straumann Group as of the date such statements are made. Forward-looking statements are neither historical facts nor assurances of future performance. They may, but need not, be identified by words such as: "anticipate," "intend," "plan," "goal," "believe," "project," "estimate," "expect," "future," "likely," "may," "should," "will" and similar references to future periods or events. Such forward-looking statements reflect the views, beliefs, assumptions and expectations of Straumann Group or its management at the time the statements are made, and they are subject to known and unknown risks, uncertainties and other factors that may be outside of Straumann Group’s control. Such known and unknown risks, uncertainties and other factors underlying forward-looking statements may cause the actual results, performance or achievements of the Group to differ materially from those expressed or implied in this document. Accordingly, you should not rely on any forward-looking statements contained in this press release. Important factors that could cause the Group’s expectations regarding future results, performance or achievements to differ materially from those expressed in a forward-looking statement include, but are not confined to, future global economic conditions, pandemics, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside Straumann Group's control. Should one or more of these risks, uncertainties or other factors materialize or should underlying views, beliefs, assumptions or expectations prove incorrect, actual outcomes may vary materially from those forecasted or expected. Straumann Group is providing the information in this release as of the date it is issued and does not undertake any obligation to update any statements as a result of new information, future events or otherwise.This release constitutes neither an offer to sell nor a solicitation to buy any securities.

 



End of Media Release


Language: English
Company: Straumann Holding AG
Peter Merian-Weg 12
4052 Basel
Switzerland
Phone: +41619651239
Fax: +41 61 965 11 06
E-mail: jana.erdmann@straumann.com
Internet: www.straumann-group.com
ISIN: CH1175448666
Valor: 914326
Listed: SIX Swiss Exchange
EQS News ID: 2115576

 
End of News EQS News Service

2115576  10.04.2025 CET/CEST

Ausgewählte Hebelprodukte auf Straumann

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Straumann

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Straumann Holding AG

Wer­bung

Analysen zu Straumann Holding AG

DatumRatingAnalyst
27.02.2013Straumann verkaufenCommerzbank AG
21.02.2013Straumann haltenVontobel Research
18.02.2013Straumann haltenVontobel Research
04.01.2013Straumann haltenVontobel Research
10.12.2012Straumann kaufenDie Actien-Börse
DatumRatingAnalyst
10.12.2012Straumann kaufenDie Actien-Börse
31.10.2012Straumann buyDeutsche Bank AG
25.10.2011Straumann buyNomura
24.08.2011Straumann buyNomura
01.10.2008Straumann per Limit bei 180 EUR einsteigenDer Aktionär
DatumRatingAnalyst
21.02.2013Straumann haltenVontobel Research
18.02.2013Straumann haltenVontobel Research
04.01.2013Straumann haltenVontobel Research
26.11.2012Straumann holdVontobel Research
26.11.2012Straumann neutralSarasin Research
DatumRatingAnalyst
27.02.2013Straumann verkaufenCommerzbank AG
01.11.2012Straumann underperformExane-BNP Paribas SA
30.10.2012Straumann underperformCheuvreux SA
25.10.2012Straumann underperformExane-BNP Paribas SA
27.08.2012Straumann reduceCommerzbank Corp. & Markets

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Straumann Holding AG nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen